nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CLCN2—artery—coronary artery disease	0.0464	0.28	CbGeAlD
Lubiprostone—CLCN2—endothelium—coronary artery disease	0.0392	0.237	CbGeAlD
Lubiprostone—CLCN2—heart—coronary artery disease	0.0171	0.103	CbGeAlD
Lubiprostone—CLCN2—cardiovascular system—coronary artery disease	0.0161	0.0973	CbGeAlD
Lubiprostone—CLCN2—blood—coronary artery disease	0.0128	0.077	CbGeAlD
Lubiprostone—CLCN2—Stimuli-sensing channels—RYR2—coronary artery disease	0.0104	0.0434	CbGpPWpGaD
Lubiprostone—CBR1—myocardium—coronary artery disease	0.00981	0.0592	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—FXYD1—coronary artery disease	0.00954	0.0398	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—ATP1A1—coronary artery disease	0.0085	0.0354	CbGpPWpGaD
Lubiprostone—CBR1—heart—coronary artery disease	0.00685	0.0414	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—RYR2—coronary artery disease	0.0068	0.0283	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—PLN—coronary artery disease	0.00661	0.0276	CbGpPWpGaD
Lubiprostone—CBR1—cardiovascular system—coronary artery disease	0.00646	0.039	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—ATP4A—coronary artery disease	0.00589	0.0246	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—CES3—coronary artery disease	0.00586	0.0244	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—PRDX6—coronary artery disease	0.00586	0.0244	CbGpPWpGaD
Lubiprostone—CBR1—cardiac atrium—coronary artery disease	0.00586	0.0354	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX2—coronary artery disease	0.00536	0.0223	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX4—coronary artery disease	0.00529	0.022	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—ATP2B1—coronary artery disease	0.00523	0.0218	CbGpPWpGaD
Lubiprostone—CBR1—blood—coronary artery disease	0.00511	0.0309	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—CYP2C19—coronary artery disease	0.00406	0.0169	CbGpPWpGaD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—coronary artery disease	0.00394	0.0164	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC6A6—coronary artery disease	0.00378	0.0157	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—ATP2A2—coronary artery disease	0.0037	0.0154	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.00332	0.0138	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTM2—coronary artery disease	0.00316	0.0132	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GGT1—coronary artery disease	0.00306	0.0127	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.00296	0.0123	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.00296	0.0123	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.00282	0.0118	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SOD3—coronary artery disease	0.00255	0.0106	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GCLM—coronary artery disease	0.00255	0.0106	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TXNRD1—coronary artery disease	0.00247	0.0103	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX1—coronary artery disease	0.00242	0.0101	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.00237	0.00986	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.00237	0.00986	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.0023	0.00959	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GPX2—coronary artery disease	0.00227	0.00947	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTA1—coronary artery disease	0.00219	0.00914	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.00214	0.00892	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.00205	0.00855	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.00205	0.00855	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GPX3—coronary artery disease	0.00184	0.00768	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.00182	0.00758	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.00182	0.00758	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.00168	0.007	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.00168	0.007	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HK1—coronary artery disease	0.00168	0.007	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GCLC—coronary artery disease	0.00166	0.00692	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPAP2B—coronary artery disease	0.00161	0.0067	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFB2—coronary artery disease	0.00158	0.00656	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—PTGS2—coronary artery disease	0.00142	0.00593	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HSPA1A—coronary artery disease	0.00139	0.00578	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HMGCS2—coronary artery disease	0.00133	0.00555	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GK—coronary artery disease	0.00133	0.00555	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GGT1—coronary artery disease	0.0013	0.00541	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.00129	0.00537	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.00126	0.00524	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CETP—coronary artery disease	0.00124	0.00518	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—UGCG—coronary artery disease	0.00122	0.00508	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.00118	0.00491	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFBR2—coronary artery disease	0.00117	0.00486	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTP1—coronary artery disease	0.00117	0.00486	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HMOX1—coronary artery disease	0.00115	0.00479	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.0011	0.00456	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTM1—coronary artery disease	0.00107	0.00446	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HGF—coronary artery disease	0.00107	0.00446	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PLIN1—coronary artery disease	0.00107	0.00444	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CA5B—coronary artery disease	0.00103	0.00431	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—AGER—coronary artery disease	0.00103	0.0043	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AKR1B1—coronary artery disease	0.000964	0.00402	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000931	0.00388	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	0.000924	0.00385	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	0.000906	0.00378	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	0.000906	0.00378	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	0.000889	0.00371	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CKMT1B—coronary artery disease	0.000879	0.00366	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.00086	0.00358	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	0.000832	0.00347	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	0.000832	0.00347	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000823	0.00343	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	0.000808	0.00336	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	0.000808	0.00336	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	0.000766	0.00319	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	0.000766	0.00319	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	0.000766	0.00319	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	0.000756	0.00315	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	0.000756	0.00315	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	0.000747	0.00311	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	0.00073	0.00304	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UQCRFS1—coronary artery disease	0.000716	0.00298	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPAP2B—coronary artery disease	0.000716	0.00298	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CKM—coronary artery disease	0.000716	0.00298	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	0.0007	0.00292	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	0.000687	0.00286	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	0.000674	0.00281	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CKMT2—coronary artery disease	0.000666	0.00278	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALDH6A1—coronary artery disease	0.000666	0.00278	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SULT4A1—coronary artery disease	0.000666	0.00278	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PYGM—coronary artery disease	0.000666	0.00278	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PDK4—coronary artery disease	0.000666	0.00278	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—APOA1—coronary artery disease	0.000651	0.00271	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LDHA—coronary artery disease	0.000594	0.00247	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GYG1—coronary artery disease	0.000594	0.00247	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HMGCS2—coronary artery disease	0.000594	0.00247	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PFKM—coronary artery disease	0.000594	0.00247	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GK—coronary artery disease	0.000594	0.00247	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GATM—coronary artery disease	0.000594	0.00247	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	0.00058	0.00242	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	0.00058	0.00242	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	0.00058	0.00242	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	0.000577	0.0024	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	0.000573	0.00239	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GCH1—coronary artery disease	0.000566	0.00236	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AK1—coronary artery disease	0.000566	0.00236	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	0.00056	0.00233	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	0.000554	0.00231	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPAT—coronary artery disease	0.000543	0.00226	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UGCG—coronary artery disease	0.000543	0.00226	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PLCD1—coronary artery disease	0.000543	0.00226	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MDH2—coronary artery disease	0.000543	0.00226	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PGM1—coronary artery disease	0.000523	0.00218	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ALB—coronary artery disease	0.000516	0.00215	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	0.000511	0.00213	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	0.000506	0.00211	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CKB—coronary artery disease	0.000505	0.0021	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PYGB—coronary artery disease	0.000505	0.0021	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTM2—coronary artery disease	0.000475	0.00198	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PFKFB3—coronary artery disease	0.000475	0.00198	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DLAT—coronary artery disease	0.000475	0.00198	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PLIN1—coronary artery disease	0.000475	0.00198	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—COX5B—coronary artery disease	0.000475	0.00198	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	0.000451	0.00188	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SULT1E1—coronary artery disease	0.00045	0.00187	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	0.000437	0.00182	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFB1—coronary artery disease	0.000437	0.00182	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AKR1B1—coronary artery disease	0.000429	0.00179	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HK2—coronary artery disease	0.000429	0.00179	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC27A1—coronary artery disease	0.000411	0.00171	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LCAT—coronary artery disease	0.000404	0.00168	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CPT1B—coronary artery disease	0.000404	0.00168	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOA4—coronary artery disease	0.000396	0.00165	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	0.000389	0.00162	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GCLM—coronary artery disease	0.000383	0.00159	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PDHA1—coronary artery disease	0.000383	0.00159	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	0.000371	0.00155	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP11B2—coronary artery disease	0.00037	0.00154	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—TXNRD1—coronary artery disease	0.00037	0.00154	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC22A3—coronary artery disease	0.000365	0.00152	CbGpPWpGaD
Lubiprostone—Headache—Fenofibrate—coronary artery disease	0.000363	0.00061	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Captopril—coronary artery disease	0.000363	0.00061	CcSEcCtD
Lubiprostone—Cough—Timolol—coronary artery disease	0.000362	0.000609	CcSEcCtD
Lubiprostone—Vomiting—Clopidogrel—coronary artery disease	0.000362	0.000609	CcSEcCtD
Lubiprostone—Diarrhoea—Simvastatin—coronary artery disease	0.000362	0.000609	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000362	0.000608	CcSEcCtD
Lubiprostone—Chest pain—Ramipril—coronary artery disease	0.000361	0.000608	CcSEcCtD
Lubiprostone—Myalgia—Ramipril—coronary artery disease	0.000361	0.000608	CcSEcCtD
Lubiprostone—Fatigue—Furosemide—coronary artery disease	0.000361	0.000607	CcSEcCtD
Lubiprostone—Tremor—Lisinopril—coronary artery disease	0.000361	0.000607	CcSEcCtD
Lubiprostone—Abdominal pain—Telmisartan—coronary artery disease	0.000361	0.000607	CcSEcCtD
Lubiprostone—Dyspnoea—Losartan—coronary artery disease	0.00036	0.000606	CcSEcCtD
Lubiprostone—Anxiety—Ramipril—coronary artery disease	0.00036	0.000606	CcSEcCtD
Lubiprostone—CBR1—Metabolism—HADH—coronary artery disease	0.00036	0.0015	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ARNTL—coronary artery disease	0.00036	0.0015	CbGpPWpGaD
Lubiprostone—Vomiting—Lovastatin—coronary artery disease	0.00036	0.000605	CcSEcCtD
Lubiprostone—Dizziness—Eplerenone—coronary artery disease	0.000359	0.000604	CcSEcCtD
Lubiprostone—Rash—Clopidogrel—coronary artery disease	0.000359	0.000604	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000359	0.000604	CcSEcCtD
Lubiprostone—Dermatitis—Clopidogrel—coronary artery disease	0.000359	0.000603	CcSEcCtD
Lubiprostone—Asthenia—Valsartan—coronary artery disease	0.000358	0.000603	CcSEcCtD
Lubiprostone—Pain—Furosemide—coronary artery disease	0.000358	0.000602	CcSEcCtD
Lubiprostone—Constipation—Furosemide—coronary artery disease	0.000358	0.000602	CcSEcCtD
Lubiprostone—Hypersensitivity—Niacin—coronary artery disease	0.000358	0.000602	CcSEcCtD
Lubiprostone—Ill-defined disorder—Lisinopril—coronary artery disease	0.000357	0.000601	CcSEcCtD
Lubiprostone—Discomfort—Ramipril—coronary artery disease	0.000357	0.000601	CcSEcCtD
Lubiprostone—Asthenia—Olmesartan—coronary artery disease	0.000357	0.0006	CcSEcCtD
Lubiprostone—Headache—Clopidogrel—coronary artery disease	0.000357	0.0006	CcSEcCtD
Lubiprostone—Rash—Lovastatin—coronary artery disease	0.000357	0.0006	CcSEcCtD
Lubiprostone—Dermatitis—Lovastatin—coronary artery disease	0.000356	0.000599	CcSEcCtD
Lubiprostone—Dyspepsia—Losartan—coronary artery disease	0.000356	0.000598	CcSEcCtD
Lubiprostone—Feeling abnormal—Perindopril—coronary artery disease	0.000355	0.000597	CcSEcCtD
Lubiprostone—Headache—Lovastatin—coronary artery disease	0.000354	0.000596	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	0.000354	0.00148	CbGpPWpGaD
Lubiprostone—Dry mouth—Ramipril—coronary artery disease	0.000353	0.000595	CcSEcCtD
Lubiprostone—Chest pain—Timolol—coronary artery disease	0.000353	0.000594	CcSEcCtD
Lubiprostone—Myalgia—Timolol—coronary artery disease	0.000353	0.000594	CcSEcCtD
Lubiprostone—Vomiting—Ezetimibe—coronary artery disease	0.000353	0.000593	CcSEcCtD
Lubiprostone—Hypersensitivity—Pravastatin—coronary artery disease	0.000352	0.000593	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Perindopril—coronary artery disease	0.000352	0.000593	CcSEcCtD
Lubiprostone—Anxiety—Timolol—coronary artery disease	0.000352	0.000592	CcSEcCtD
Lubiprostone—Decreased appetite—Losartan—coronary artery disease	0.000351	0.000591	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000351	0.00059	CcSEcCtD
Lubiprostone—Abdominal pain—Captopril—coronary artery disease	0.000351	0.00059	CcSEcCtD
Lubiprostone—Dizziness—Simvastatin—coronary artery disease	0.00035	0.000589	CcSEcCtD
Lubiprostone—Rash—Ezetimibe—coronary artery disease	0.00035	0.000588	CcSEcCtD
Lubiprostone—Dermatitis—Ezetimibe—coronary artery disease	0.000349	0.000588	CcSEcCtD
Lubiprostone—Discomfort—Timolol—coronary artery disease	0.000349	0.000587	CcSEcCtD
Lubiprostone—Asthenia—Niacin—coronary artery disease	0.000348	0.000586	CcSEcCtD
Lubiprostone—Fatigue—Losartan—coronary artery disease	0.000348	0.000586	CcSEcCtD
Lubiprostone—Headache—Ezetimibe—coronary artery disease	0.000347	0.000585	CcSEcCtD
Lubiprostone—Malaise—Lisinopril—coronary artery disease	0.000347	0.000584	CcSEcCtD
Lubiprostone—Oedema—Ramipril—coronary artery disease	0.000346	0.000583	CcSEcCtD
Lubiprostone—Dry mouth—Timolol—coronary artery disease	0.000346	0.000581	CcSEcCtD
Lubiprostone—Constipation—Losartan—coronary artery disease	0.000345	0.000581	CcSEcCtD
Lubiprostone—Pain—Losartan—coronary artery disease	0.000345	0.000581	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	0.000345	0.00144	CbGpPWpGaD
Lubiprostone—Syncope—Lisinopril—coronary artery disease	0.000345	0.000581	CcSEcCtD
Lubiprostone—Vomiting—Eplerenone—coronary artery disease	0.000345	0.000581	CcSEcCtD
Lubiprostone—Feeling abnormal—Furosemide—coronary artery disease	0.000345	0.000581	CcSEcCtD
Lubiprostone—Nausea—Fenofibrate—coronary artery disease	0.000344	0.000579	CcSEcCtD
Lubiprostone—Asthenia—Pravastatin—coronary artery disease	0.000343	0.000577	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Furosemide—coronary artery disease	0.000342	0.000576	CcSEcCtD
Lubiprostone—Rash—Eplerenone—coronary artery disease	0.000342	0.000576	CcSEcCtD
Lubiprostone—Hypersensitivity—Trandolapril—coronary artery disease	0.000342	0.000576	CcSEcCtD
Lubiprostone—Dermatitis—Eplerenone—coronary artery disease	0.000342	0.000575	CcSEcCtD
Lubiprostone—Diarrhoea—Valsartan—coronary artery disease	0.000342	0.000575	CcSEcCtD
Lubiprostone—CBR1—Metabolism—APOA2—coronary artery disease	0.000341	0.00142	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPX2—coronary artery disease	0.000341	0.00142	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PLA2G2A—coronary artery disease	0.000341	0.00142	CbGpPWpGaD
Lubiprostone—Shock—Ramipril—coronary artery disease	0.000341	0.000573	CcSEcCtD
Lubiprostone—Hypersensitivity—Enalapril—coronary artery disease	0.000341	0.000573	CcSEcCtD
Lubiprostone—Abdominal pain—Perindopril—coronary artery disease	0.000341	0.000573	CcSEcCtD
Lubiprostone—Palpitations—Lisinopril—coronary artery disease	0.00034	0.000572	CcSEcCtD
Lubiprostone—Diarrhoea—Olmesartan—coronary artery disease	0.00034	0.000572	CcSEcCtD
Lubiprostone—Headache—Eplerenone—coronary artery disease	0.00034	0.000572	CcSEcCtD
Lubiprostone—Nervous system disorder—Ramipril—coronary artery disease	0.00034	0.000572	CcSEcCtD
Lubiprostone—Oedema—Timolol—coronary artery disease	0.000339	0.00057	CcSEcCtD
Lubiprostone—Loss of consciousness—Lisinopril—coronary artery disease	0.000338	0.000569	CcSEcCtD
Lubiprostone—Nausea—Clopidogrel—coronary artery disease	0.000338	0.000569	CcSEcCtD
Lubiprostone—Tachycardia—Ramipril—coronary artery disease	0.000338	0.000569	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ABCG5—coronary artery disease	0.000337	0.0014	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SULT1A1—coronary artery disease	0.000337	0.0014	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPX4—coronary artery disease	0.000337	0.0014	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HK1—coronary artery disease	0.000337	0.0014	CbGpPWpGaD
Lubiprostone—Skin disorder—Ramipril—coronary artery disease	0.000336	0.000566	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	0.000336	0.0014	CbGpPWpGaD
Lubiprostone—Vomiting—Simvastatin—coronary artery disease	0.000336	0.000566	CcSEcCtD
Lubiprostone—Hypersensitivity—Telmisartan—coronary artery disease	0.000336	0.000566	CcSEcCtD
Lubiprostone—Cough—Lisinopril—coronary artery disease	0.000336	0.000565	CcSEcCtD
Lubiprostone—Nausea—Lovastatin—coronary artery disease	0.000336	0.000565	CcSEcCtD
Lubiprostone—Hyperhidrosis—Ramipril—coronary artery disease	0.000335	0.000563	CcSEcCtD
Lubiprostone—Rash—Simvastatin—coronary artery disease	0.000334	0.000561	CcSEcCtD
Lubiprostone—Dermatitis—Simvastatin—coronary artery disease	0.000333	0.000561	CcSEcCtD
Lubiprostone—Asthenia—Trandolapril—coronary artery disease	0.000333	0.000561	CcSEcCtD
Lubiprostone—Shock—Timolol—coronary artery disease	0.000333	0.000561	CcSEcCtD
Lubiprostone—Feeling abnormal—Losartan—coronary artery disease	0.000333	0.00056	CcSEcCtD
Lubiprostone—CBR1—Metabolism—HADHA—coronary artery disease	0.000333	0.00139	CbGpPWpGaD
Lubiprostone—Diarrhoea—Niacin—coronary artery disease	0.000332	0.000559	CcSEcCtD
Lubiprostone—Nervous system disorder—Timolol—coronary artery disease	0.000332	0.000559	CcSEcCtD
Lubiprostone—Asthenia—Enalapril—coronary artery disease	0.000332	0.000558	CcSEcCtD
Lubiprostone—Headache—Simvastatin—coronary artery disease	0.000331	0.000558	CcSEcCtD
Lubiprostone—Abdominal pain—Furosemide—coronary artery disease	0.000331	0.000557	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Losartan—coronary artery disease	0.00033	0.000556	CcSEcCtD
Lubiprostone—Dizziness—Valsartan—coronary artery disease	0.00033	0.000556	CcSEcCtD
Lubiprostone—Anorexia—Ramipril—coronary artery disease	0.00033	0.000556	CcSEcCtD
Lubiprostone—Nausea—Ezetimibe—coronary artery disease	0.000329	0.000554	CcSEcCtD
Lubiprostone—Skin disorder—Timolol—coronary artery disease	0.000329	0.000553	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTA1—coronary artery disease	0.000329	0.00137	CbGpPWpGaD
Lubiprostone—Dizziness—Olmesartan—coronary artery disease	0.000329	0.000553	CcSEcCtD
Lubiprostone—Chest pain—Lisinopril—coronary artery disease	0.000328	0.000551	CcSEcCtD
Lubiprostone—Myalgia—Lisinopril—coronary artery disease	0.000328	0.000551	CcSEcCtD
Lubiprostone—Hyperhidrosis—Timolol—coronary artery disease	0.000327	0.000551	CcSEcCtD
Lubiprostone—Asthenia—Telmisartan—coronary artery disease	0.000327	0.000551	CcSEcCtD
Lubiprostone—Diarrhoea—Pravastatin—coronary artery disease	0.000327	0.000551	CcSEcCtD
Lubiprostone—Anxiety—Lisinopril—coronary artery disease	0.000327	0.00055	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000325	0.000548	CcSEcCtD
Lubiprostone—CBR1—Metabolism—LPA—coronary artery disease	0.000325	0.00136	CbGpPWpGaD
Lubiprostone—Discomfort—Lisinopril—coronary artery disease	0.000324	0.000545	CcSEcCtD
Lubiprostone—Anorexia—Timolol—coronary artery disease	0.000323	0.000543	CcSEcCtD
Lubiprostone—Nausea—Eplerenone—coronary artery disease	0.000322	0.000543	CcSEcCtD
Lubiprostone—Dizziness—Niacin—coronary artery disease	0.000321	0.00054	CcSEcCtD
Lubiprostone—Dry mouth—Lisinopril—coronary artery disease	0.000321	0.000539	CcSEcCtD
Lubiprostone—Abdominal pain—Losartan—coronary artery disease	0.000319	0.000537	CcSEcCtD
Lubiprostone—Asthenia—Captopril—coronary artery disease	0.000318	0.000536	CcSEcCtD
Lubiprostone—Diarrhoea—Trandolapril—coronary artery disease	0.000318	0.000535	CcSEcCtD
Lubiprostone—Vomiting—Valsartan—coronary artery disease	0.000318	0.000534	CcSEcCtD
Lubiprostone—Diarrhoea—Enalapril—coronary artery disease	0.000316	0.000532	CcSEcCtD
Lubiprostone—Dizziness—Pravastatin—coronary artery disease	0.000316	0.000532	CcSEcCtD
Lubiprostone—Vomiting—Olmesartan—coronary artery disease	0.000316	0.000532	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000316	0.000531	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PLCB3—coronary artery disease	0.000315	0.00131	CbGpPWpGaD
Lubiprostone—Rash—Valsartan—coronary artery disease	0.000315	0.00053	CcSEcCtD
Lubiprostone—Dermatitis—Valsartan—coronary artery disease	0.000315	0.000529	CcSEcCtD
Lubiprostone—Nausea—Simvastatin—coronary artery disease	0.000314	0.000529	CcSEcCtD
Lubiprostone—Oedema—Lisinopril—coronary artery disease	0.000314	0.000529	CcSEcCtD
Lubiprostone—Rash—Olmesartan—coronary artery disease	0.000313	0.000527	CcSEcCtD
Lubiprostone—Dermatitis—Olmesartan—coronary artery disease	0.000313	0.000527	CcSEcCtD
Lubiprostone—Headache—Valsartan—coronary artery disease	0.000313	0.000527	CcSEcCtD
Lubiprostone—Diarrhoea—Telmisartan—coronary artery disease	0.000312	0.000525	CcSEcCtD
Lubiprostone—CBR1—Metabolism—APOA5—coronary artery disease	0.000312	0.0013	CbGpPWpGaD
Lubiprostone—Headache—Olmesartan—coronary artery disease	0.000311	0.000524	CcSEcCtD
Lubiprostone—Shock—Lisinopril—coronary artery disease	0.000309	0.00052	CcSEcCtD
Lubiprostone—Asthenia—Perindopril—coronary artery disease	0.000309	0.00052	CcSEcCtD
Lubiprostone—Dyspnoea—Ramipril—coronary artery disease	0.000309	0.00052	CcSEcCtD
Lubiprostone—Vomiting—Niacin—coronary artery disease	0.000309	0.00052	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000309	0.000519	CcSEcCtD
Lubiprostone—Hypersensitivity—Furosemide—coronary artery disease	0.000309	0.000519	CcSEcCtD
Lubiprostone—Dizziness—Trandolapril—coronary artery disease	0.000307	0.000517	CcSEcCtD
Lubiprostone—Tachycardia—Lisinopril—coronary artery disease	0.000307	0.000516	CcSEcCtD
Lubiprostone—Rash—Niacin—coronary artery disease	0.000306	0.000515	CcSEcCtD
Lubiprostone—Dermatitis—Niacin—coronary artery disease	0.000306	0.000515	CcSEcCtD
Lubiprostone—Dizziness—Enalapril—coronary artery disease	0.000306	0.000515	CcSEcCtD
Lubiprostone—CBR1—Metabolism—P4HB—coronary artery disease	0.000306	0.00127	CbGpPWpGaD
Lubiprostone—Skin disorder—Lisinopril—coronary artery disease	0.000305	0.000513	CcSEcCtD
Lubiprostone—Dyspepsia—Ramipril—coronary artery disease	0.000305	0.000513	CcSEcCtD
Lubiprostone—Headache—Niacin—coronary artery disease	0.000304	0.000512	CcSEcCtD
Lubiprostone—Vomiting—Pravastatin—coronary artery disease	0.000304	0.000512	CcSEcCtD
Lubiprostone—Hyperhidrosis—Lisinopril—coronary artery disease	0.000304	0.000511	CcSEcCtD
Lubiprostone—Diarrhoea—Captopril—coronary artery disease	0.000304	0.000511	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	0.000303	0.00126	CbGpPWpGaD
Lubiprostone—Dyspnoea—Timolol—coronary artery disease	0.000302	0.000508	CcSEcCtD
Lubiprostone—Dizziness—Telmisartan—coronary artery disease	0.000302	0.000508	CcSEcCtD
Lubiprostone—Rash—Pravastatin—coronary artery disease	0.000302	0.000507	CcSEcCtD
Lubiprostone—Dermatitis—Pravastatin—coronary artery disease	0.000301	0.000507	CcSEcCtD
Lubiprostone—Decreased appetite—Ramipril—coronary artery disease	0.000301	0.000507	CcSEcCtD
Lubiprostone—Asthenia—Furosemide—coronary artery disease	0.0003	0.000505	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PLA2G1B—coronary artery disease	0.0003	0.00125	CbGpPWpGaD
Lubiprostone—Headache—Pravastatin—coronary artery disease	0.0003	0.000504	CcSEcCtD
Lubiprostone—Anorexia—Lisinopril—coronary artery disease	0.000299	0.000504	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000299	0.000503	CcSEcCtD
Lubiprostone—Fatigue—Ramipril—coronary artery disease	0.000299	0.000503	CcSEcCtD
Lubiprostone—Dyspepsia—Timolol—coronary artery disease	0.000298	0.000502	CcSEcCtD
Lubiprostone—Hypersensitivity—Losartan—coronary artery disease	0.000298	0.000501	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	0.000297	0.00124	CbGpPWpGaD
Lubiprostone—Nausea—Valsartan—coronary artery disease	0.000297	0.000499	CcSEcCtD
Lubiprostone—Constipation—Ramipril—coronary artery disease	0.000296	0.000498	CcSEcCtD
Lubiprostone—Nausea—Olmesartan—coronary artery disease	0.000295	0.000497	CcSEcCtD
Lubiprostone—Vomiting—Trandolapril—coronary artery disease	0.000295	0.000497	CcSEcCtD
Lubiprostone—Diarrhoea—Perindopril—coronary artery disease	0.000295	0.000496	CcSEcCtD
Lubiprostone—Decreased appetite—Timolol—coronary artery disease	0.000294	0.000495	CcSEcCtD
Lubiprostone—Vomiting—Enalapril—coronary artery disease	0.000294	0.000495	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	0.000293	0.00122	CbGpPWpGaD
Lubiprostone—Dizziness—Captopril—coronary artery disease	0.000293	0.000494	CcSEcCtD
Lubiprostone—Rash—Trandolapril—coronary artery disease	0.000293	0.000493	CcSEcCtD
Lubiprostone—Dermatitis—Trandolapril—coronary artery disease	0.000293	0.000492	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Timolol—coronary artery disease	0.000292	0.000492	CcSEcCtD
Lubiprostone—Fatigue—Timolol—coronary artery disease	0.000292	0.000491	CcSEcCtD
Lubiprostone—Rash—Enalapril—coronary artery disease	0.000292	0.000491	CcSEcCtD
Lubiprostone—Dermatitis—Enalapril—coronary artery disease	0.000291	0.00049	CcSEcCtD
Lubiprostone—Headache—Trandolapril—coronary artery disease	0.000291	0.00049	CcSEcCtD
Lubiprostone—Vomiting—Telmisartan—coronary artery disease	0.00029	0.000488	CcSEcCtD
Lubiprostone—Asthenia—Losartan—coronary artery disease	0.00029	0.000488	CcSEcCtD
Lubiprostone—Headache—Enalapril—coronary artery disease	0.00029	0.000488	CcSEcCtD
Lubiprostone—Pain—Timolol—coronary artery disease	0.00029	0.000487	CcSEcCtD
Lubiprostone—Nausea—Niacin—coronary artery disease	0.000289	0.000485	CcSEcCtD
Lubiprostone—Rash—Telmisartan—coronary artery disease	0.000288	0.000484	CcSEcCtD
Lubiprostone—Dermatitis—Telmisartan—coronary artery disease	0.000287	0.000484	CcSEcCtD
Lubiprostone—Diarrhoea—Furosemide—coronary artery disease	0.000287	0.000482	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000286	0.000482	CcSEcCtD
Lubiprostone—Headache—Telmisartan—coronary artery disease	0.000286	0.000481	CcSEcCtD
Lubiprostone—Feeling abnormal—Ramipril—coronary artery disease	0.000285	0.00048	CcSEcCtD
Lubiprostone—Dizziness—Perindopril—coronary artery disease	0.000285	0.000479	CcSEcCtD
Lubiprostone—Nausea—Pravastatin—coronary artery disease	0.000284	0.000478	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Ramipril—coronary artery disease	0.000283	0.000477	CcSEcCtD
Lubiprostone—CBR1—Metabolism—VCAN—coronary artery disease	0.000283	0.00118	CbGpPWpGaD
Lubiprostone—Vomiting—Captopril—coronary artery disease	0.000282	0.000475	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ALDOA—coronary artery disease	0.000281	0.00117	CbGpPWpGaD
Lubiprostone—Dyspnoea—Lisinopril—coronary artery disease	0.00028	0.000471	CcSEcCtD
Lubiprostone—Rash—Captopril—coronary artery disease	0.00028	0.000471	CcSEcCtD
Lubiprostone—Dermatitis—Captopril—coronary artery disease	0.000279	0.00047	CcSEcCtD
Lubiprostone—Feeling abnormal—Timolol—coronary artery disease	0.000279	0.00047	CcSEcCtD
Lubiprostone—Headache—Captopril—coronary artery disease	0.000278	0.000468	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Timolol—coronary artery disease	0.000277	0.000466	CcSEcCtD
Lubiprostone—Dizziness—Furosemide—coronary artery disease	0.000277	0.000466	CcSEcCtD
Lubiprostone—Dyspepsia—Lisinopril—coronary artery disease	0.000277	0.000465	CcSEcCtD
Lubiprostone—Diarrhoea—Losartan—coronary artery disease	0.000276	0.000465	CcSEcCtD
Lubiprostone—Nausea—Trandolapril—coronary artery disease	0.000276	0.000464	CcSEcCtD
Lubiprostone—Nausea—Enalapril—coronary artery disease	0.000275	0.000462	CcSEcCtD
Lubiprostone—Vomiting—Perindopril—coronary artery disease	0.000274	0.000461	CcSEcCtD
Lubiprostone—Abdominal pain—Ramipril—coronary artery disease	0.000274	0.000461	CcSEcCtD
Lubiprostone—Decreased appetite—Lisinopril—coronary artery disease	0.000273	0.00046	CcSEcCtD
Lubiprostone—CBR1—Metabolism—DCN—coronary artery disease	0.000273	0.00114	CbGpPWpGaD
Lubiprostone—Rash—Perindopril—coronary artery disease	0.000272	0.000457	CcSEcCtD
Lubiprostone—Dermatitis—Perindopril—coronary artery disease	0.000271	0.000457	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000271	0.000456	CcSEcCtD
Lubiprostone—Nausea—Telmisartan—coronary artery disease	0.000271	0.000456	CcSEcCtD
Lubiprostone—Fatigue—Lisinopril—coronary artery disease	0.000271	0.000456	CcSEcCtD
Lubiprostone—Headache—Perindopril—coronary artery disease	0.00027	0.000454	CcSEcCtD
Lubiprostone—Pain—Lisinopril—coronary artery disease	0.000269	0.000452	CcSEcCtD
Lubiprostone—Constipation—Lisinopril—coronary artery disease	0.000269	0.000452	CcSEcCtD
Lubiprostone—Abdominal pain—Timolol—coronary artery disease	0.000268	0.00045	CcSEcCtD
Lubiprostone—Dizziness—Losartan—coronary artery disease	0.000267	0.00045	CcSEcCtD
Lubiprostone—Vomiting—Furosemide—coronary artery disease	0.000266	0.000448	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ALDH2—coronary artery disease	0.000265	0.0011	CbGpPWpGaD
Lubiprostone—Rash—Furosemide—coronary artery disease	0.000264	0.000444	CcSEcCtD
Lubiprostone—Dermatitis—Furosemide—coronary artery disease	0.000264	0.000444	CcSEcCtD
Lubiprostone—Nausea—Captopril—coronary artery disease	0.000264	0.000443	CcSEcCtD
Lubiprostone—Headache—Furosemide—coronary artery disease	0.000262	0.000441	CcSEcCtD
Lubiprostone—Feeling abnormal—Lisinopril—coronary artery disease	0.000259	0.000436	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	0.000259	0.00108	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3C2A—coronary artery disease	0.000258	0.00108	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP2C19—coronary artery disease	0.000258	0.00108	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LIPC—coronary artery disease	0.000258	0.00108	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HBA1—coronary artery disease	0.000258	0.00108	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000257	0.000432	CcSEcCtD
Lubiprostone—Vomiting—Losartan—coronary artery disease	0.000257	0.000432	CcSEcCtD
Lubiprostone—CBR1—Metabolism—APOC3—coronary artery disease	0.000257	0.00107	CbGpPWpGaD
Lubiprostone—Nausea—Perindopril—coronary artery disease	0.000256	0.00043	CcSEcCtD
Lubiprostone—CBR1—Metabolism—LDLR—coronary artery disease	0.000255	0.00106	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Ramipril—coronary artery disease	0.000255	0.000429	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	0.000255	0.00106	CbGpPWpGaD
Lubiprostone—Rash—Losartan—coronary artery disease	0.000255	0.000429	CcSEcCtD
Lubiprostone—Dermatitis—Losartan—coronary artery disease	0.000255	0.000428	CcSEcCtD
Lubiprostone—Headache—Losartan—coronary artery disease	0.000253	0.000426	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SLC9A1—coronary artery disease	0.000252	0.00105	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTT1—coronary artery disease	0.000252	0.00105	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Timolol—coronary artery disease	0.00025	0.00042	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CETP—coronary artery disease	0.000249	0.00104	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GCLC—coronary artery disease	0.000249	0.00104	CbGpPWpGaD
Lubiprostone—Nausea—Furosemide—coronary artery disease	0.000249	0.000418	CcSEcCtD
Lubiprostone—Asthenia—Ramipril—coronary artery disease	0.000249	0.000418	CcSEcCtD
Lubiprostone—Abdominal pain—Lisinopril—coronary artery disease	0.000248	0.000418	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SDC1—coronary artery disease	0.000247	0.00103	CbGpPWpGaD
Lubiprostone—Asthenia—Timolol—coronary artery disease	0.000243	0.000409	CcSEcCtD
Lubiprostone—Nausea—Losartan—coronary artery disease	0.00024	0.000404	CcSEcCtD
Lubiprostone—Diarrhoea—Ramipril—coronary artery disease	0.000237	0.000399	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PSMB5—coronary artery disease	0.000233	0.00097	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PSMA6—coronary artery disease	0.000233	0.00097	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	0.000232	0.000968	CbGpPWpGaD
Lubiprostone—Diarrhoea—Timolol—coronary artery disease	0.000232	0.00039	CcSEcCtD
Lubiprostone—Hypersensitivity—Lisinopril—coronary artery disease	0.000231	0.000389	CcSEcCtD
Lubiprostone—Dizziness—Ramipril—coronary artery disease	0.000229	0.000385	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CTGF—coronary artery disease	0.000227	0.000948	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GOT2—coronary artery disease	0.000225	0.000939	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HMGCR—coronary artery disease	0.000225	0.000939	CbGpPWpGaD
Lubiprostone—Asthenia—Lisinopril—coronary artery disease	0.000225	0.000379	CcSEcCtD
Lubiprostone—Dizziness—Timolol—coronary artery disease	0.000224	0.000377	CcSEcCtD
Lubiprostone—Vomiting—Ramipril—coronary artery disease	0.00022	0.000371	CcSEcCtD
Lubiprostone—Rash—Ramipril—coronary artery disease	0.000218	0.000368	CcSEcCtD
Lubiprostone—Dermatitis—Ramipril—coronary artery disease	0.000218	0.000367	CcSEcCtD
Lubiprostone—Headache—Ramipril—coronary artery disease	0.000217	0.000365	CcSEcCtD
Lubiprostone—Vomiting—Timolol—coronary artery disease	0.000215	0.000362	CcSEcCtD
Lubiprostone—Diarrhoea—Lisinopril—coronary artery disease	0.000215	0.000362	CcSEcCtD
Lubiprostone—Rash—Timolol—coronary artery disease	0.000214	0.000359	CcSEcCtD
Lubiprostone—Dermatitis—Timolol—coronary artery disease	0.000213	0.000359	CcSEcCtD
Lubiprostone—Headache—Timolol—coronary artery disease	0.000212	0.000357	CcSEcCtD
Lubiprostone—Dizziness—Lisinopril—coronary artery disease	0.000208	0.00035	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PLCB1—coronary artery disease	0.000207	0.000864	CbGpPWpGaD
Lubiprostone—Nausea—Ramipril—coronary artery disease	0.000206	0.000346	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	0.000203	0.000847	CbGpPWpGaD
Lubiprostone—Nausea—Timolol—coronary artery disease	0.000201	0.000338	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ABCA1—coronary artery disease	0.000201	0.000837	CbGpPWpGaD
Lubiprostone—Vomiting—Lisinopril—coronary artery disease	0.0002	0.000336	CcSEcCtD
Lubiprostone—Rash—Lisinopril—coronary artery disease	0.000198	0.000333	CcSEcCtD
Lubiprostone—Dermatitis—Lisinopril—coronary artery disease	0.000198	0.000333	CcSEcCtD
Lubiprostone—Headache—Lisinopril—coronary artery disease	0.000197	0.000331	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GOT1—coronary artery disease	0.000195	0.000811	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GGT1—coronary artery disease	0.000195	0.000811	CbGpPWpGaD
Lubiprostone—Nausea—Lisinopril—coronary artery disease	0.000187	0.000314	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTP1—coronary artery disease	0.000175	0.000728	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARGC1A—coronary artery disease	0.000173	0.000722	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HMOX1—coronary artery disease	0.000172	0.000718	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CAT—coronary artery disease	0.00017	0.000709	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOB—coronary artery disease	0.000165	0.000688	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTM1—coronary artery disease	0.000161	0.000669	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LPL—coronary artery disease	0.000158	0.000657	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPX1—coronary artery disease	0.000154	0.000641	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CD36—coronary artery disease	0.00015	0.000624	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPP2CA—coronary artery disease	0.000148	0.000616	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MTHFR—coronary artery disease	0.000142	0.000592	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AGT—coronary artery disease	0.000135	0.000562	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOE—coronary artery disease	0.000132	0.000551	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOA1—coronary artery disease	0.000131	0.000544	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	0.000125	0.000521	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARG—coronary artery disease	0.000115	0.00048	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—POMC—coronary artery disease	0.000114	0.000473	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALB—coronary artery disease	0.000104	0.000431	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NOS3—coronary artery disease	9.9e-05	0.000413	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTGS2—coronary artery disease	9.06e-05	0.000377	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CA—coronary artery disease	5.57e-05	0.000232	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AKT1—coronary artery disease	4.55e-05	0.00019	CbGpPWpGaD
